The US FDA conducted a periodic cGMP inspection of our Drug Substance manufacturing site at Bangalore Campus from Sep 17 - 21, 2018. The weeklong audit concluded without any observations and no Form 483 was issued. The successful audit of this site reflects our strong commitment to cGMP compliance.
Shares of BIOCON LTD. was last trading in BSE at Rs.676.1 as compared to the previous close of Rs. 669.35. The total number of shares traded during the day was 375163 in over 6115 trades.
The stock hit an intraday high of Rs. 690.9 and intraday low of 657. The net turnover during the day was Rs. 255145908.